New Delhi, September 23: Cosmetics and hygiene products maker Procter & Gamble Hygiene and Health Care (PGHH) has officially addressed rumors of a potential delisting, denying them even as the company’s financials remain weak in Q1 FY27 amid commodity pricing pressures.
The company recorded a 5% decline in standalone sales at ₹901 crore for the quarter, with net profits standing at ₹126 crore, down from ₹192.06 crore recorded during the same period last year. Higher advertising costs also contributed to the lower margin realisations, with revenues falling 4.9% to ₹891.46 crore from ₹937.03 crore from the same period last year.
The stock has fallen more than 46% in the last one year, reaching ₹7,190 as the company faces fiere rivalry from Johnson and Johnson, Unicharm and other FMCG players nibbling at its flagship brands Whisper, Vicks and Old Spice.
The management is looking to address this by strengthening its brands and boosting operational efficiencies even as it looks to regain trust with innovations and a boost in supplies.
The rumours have impacted the brand’s perceptions amongst investors, but the company has a lot on its plate to regain trust as it faces fresh challenges from all sides.
Disclaimer: This article is for informational purposes only and does not constitute financial advice. Investing in stocks includes financial risks, and past performance is not indicative of future results. Readers should conduct their own research or consult with a qualified financial advisor before making any investment decisions.
